NCT05646433 (TU-GIBscore) is a clinical trial in Gastro Intestinal Bleed, sponsored by Hôpital Universitaire Sahloul.

Who is sponsoring NCT05646433?

NCT05646433 is sponsored by Hôpital Universitaire Sahloul.

What condition does NCT05646433 study?

NCT05646433 studies Gastro Intestinal Bleed.

Is NCT05646433 still recruiting?

NCT05646433 is currently status unknown. Last updated 6 July 2023.

Last reviewed 2023-07-06 · How we verify

NCT05646433: TU-GIBscore

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Validation of a New Score for UGI Bleeding in the ED: the Study of the TU-GIB Score

Status unknown Last updated 6 July 2023

What this trial tests

trial in Gastro Intestinal Bleed in 500 participants. Status unknown.

Timeline

2 June 2023

Primary endpoint
1 December 2023

31 December 2023

Quick facts

Lead sponsor	Hôpital Universitaire Sahloul
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	2 June 2023
Primary completion	1 December 2023
Estimated completion	31 December 2023
Sites	1 location across Tunisia

Conditions studied

Gastro Intestinal Bleed — all drugs for Gastro Intestinal Bleed →

Sponsor

Hôpital Universitaire Sahloul — full company profile →

Who can join

Adults 18 to 90, any sex, with Gastro Intestinal Bleed. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We have developed a new reliable, easy and reproducible clinical and biological score to select patients presenting to the emergency department with upper GI bleeding and at high risk of developing complications in order to plan an adequate management. This score was compared to the Glasgow-Blatchford score and showed better results in predicting rebleeding, the need for hemostasis therapy and any complications at day 30 including mortality. In a second step and as an objective of this study, it is necessary to perform an external validation of this score in different emergency departments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hôpital Universitaire Sahloul trials

Trials by the same sponsor.

NCT07329881 — Artificial Intelligence Algorithm for the Interpretation of Traumatic Bone Radiographs · active not recruiting
NCT07147699 — Evaluation of the Effectiveness of the CardioStory Device in Distinguishing Heart Failure From Other Causes in Patients · not yet recruiting
NCT07089277 — External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population · recruiting
NCT06953154 — Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities · completed
NCT05670444 — Melatonin, Vitamins and Minerals Supplements for the Treatment of Covid-19 and Covid-like Illness · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05646433 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hôpital Universitaire Sahloul
Last refreshed: 6 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05646433.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing